HEADER HYDROLASE 26-OCT-00 1G49 TITLE A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MATRIX METALLOPROTEINASE 3; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 SYNONYM: STROMELYSIN 1, MMP3, PROGELATINASE, TRANSIN-1, SL-1; COMPND 6 EC: 3.4.24.17; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL: FIBROBLAST; SOURCE 6 GENE: MMP3; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MIXED ALPHA BETA STRUCTURE, ZINC PROTEASE, INHIBITED, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.G.NATCHUS,R.G.BOOKLAND,B.DE,N.G.ALMSTEAD,S.PIKUL REVDAT 4 07-FEB-24 1G49 1 REMARK LINK REVDAT 3 04-OCT-17 1G49 1 REMARK REVDAT 2 24-FEB-09 1G49 1 VERSN REVDAT 1 24-OCT-01 1G49 0 JRNL AUTH M.G.NATCHUS,R.G.BOOKLAND,B.DE,N.G.ALMSTEAD,S.PIKUL JRNL TITL DEVELOPMENT OF NEW HYDROXAMATE MATRIX METALLOPROTEINASE JRNL TITL 2 INHIBITORS DERIVED FROM FUNCTIONALIZED 4-AMINOPROLINES. JRNL REF J.MED.CHEM. V. 43 4948 2000 JRNL REFN ISSN 0022-2623 JRNL PMID 11150165 JRNL DOI 10.1021/JM000246E REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 16944 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 11.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1856 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2722 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 111 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.30000 REMARK 3 B22 (A**2) : 0.30000 REMARK 3 B33 (A**2) : -0.60000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.016 ; NULL REMARK 3 ANGLE DISTANCE (A) : 1.900 ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: USED MAXIMUM LIKELIHOOD PROCEDURES REMARK 4 REMARK 4 1G49 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-NOV-00. REMARK 100 THE DEPOSITION ID IS D_1000012213. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-MAR-00 REMARK 200 TEMPERATURE (KELVIN) : 173 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22034 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 62.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 72.8 REMARK 200 DATA REDUNDANCY : 1.600 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 30.7 REMARK 200 DATA REDUNDANCY IN SHELL : 1.30 REMARK 200 R MERGE FOR SHELL (I) : 0.22500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CCP4 (FFT) REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, NACL, MGCL2, TRIS, PH 8.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP AT 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 18.83400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.07250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.55600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.07250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 18.83400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.55600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER CONSTRUCTED FROM CHAIN REMARK 300 A OR CHAIN B REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 252 REMARK 465 PRO A 253 REMARK 465 GLU A 254 REMARK 465 THR A 255 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG B 584 O HOH B 85 1.92 REMARK 500 OE1 GLU B 754 O HOH B 103 2.00 REMARK 500 O HOH A 327 O HOH A 364 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O ILE A 89 OE2 GLU B 716 2564 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 600 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 ASP B 683 CB - CG - OD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 ASP B 728 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 PRO B 753 CB - CA - C ANGL. DEV. = -16.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 149 -127.22 45.51 REMARK 500 HIS A 151 19.90 -144.76 REMARK 500 ASN A 162 -120.36 60.27 REMARK 500 ASP A 189 -157.71 -118.63 REMARK 500 PRO A 221 -5.15 -56.54 REMARK 500 LEU A 226 92.91 -47.55 REMARK 500 ARG B 649 -128.64 44.76 REMARK 500 HIS B 651 27.48 -145.40 REMARK 500 ASN B 662 -129.57 49.17 REMARK 500 ASP B 689 -154.52 -112.45 REMARK 500 PRO B 721 31.12 -71.56 REMARK 500 SER B 725 48.43 -105.69 REMARK 500 ARG B 731 54.17 -90.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 304 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 107 OD1 REMARK 620 2 ASP A 107 OD2 48.7 REMARK 620 3 ASP A 182 O 161.8 147.4 REMARK 620 4 ASP A 182 OD1 93.0 83.2 83.5 REMARK 620 5 GLU A 184 O 119.2 77.0 78.8 107.3 REMARK 620 6 HOH A 314 O 84.0 98.1 97.9 174.5 78.2 REMARK 620 7 HOH A 316 O 82.1 130.1 80.2 93.2 148.7 81.9 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 305 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 141 O REMARK 620 2 GLY A 173 O 170.1 REMARK 620 3 ASN A 175 O 105.5 84.2 REMARK 620 4 ASP A 177 OD1 83.6 93.4 96.9 REMARK 620 5 HOH A 325 O 87.4 96.2 81.2 169.9 REMARK 620 6 HOH A 326 O 89.0 81.7 163.1 93.3 91.0 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 302 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 151 NE2 REMARK 620 2 ASP A 153 OD2 109.2 REMARK 620 3 HIS A 166 NE2 110.0 114.9 REMARK 620 4 HIS A 179 ND1 107.2 98.1 116.7 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 303 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 158 OD1 REMARK 620 2 GLY A 159 O 89.4 REMARK 620 3 GLY A 161 O 91.7 88.0 REMARK 620 4 VAL A 163 O 87.7 177.0 91.5 REMARK 620 5 ASP A 181 OD2 88.8 84.9 172.9 95.6 REMARK 620 6 GLU A 184 OE2 176.7 93.9 87.7 89.0 92.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 201 NE2 REMARK 620 2 HIS A 205 NE2 103.6 REMARK 620 3 HIS A 211 NE2 112.5 105.8 REMARK 620 4 THR B 755 O 98.1 102.5 131.2 REMARK 620 5 THR B 755 OXT 140.6 107.2 82.1 51.7 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 805 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH B 40 O REMARK 620 2 HOH B 44 O 89.5 REMARK 620 3 ASP B 641 O 90.8 88.5 REMARK 620 4 GLY B 673 O 77.8 90.0 168.5 REMARK 620 5 ASN B 675 O 163.4 82.1 103.2 87.9 REMARK 620 6 ASP B 677 OD1 92.5 176.8 88.8 93.0 96.6 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 804 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH B 60 O REMARK 620 2 HOH B 86 O 86.1 REMARK 620 3 ASP B 607 OD2 130.2 101.3 REMARK 620 4 ASP B 607 OD1 81.2 83.9 51.5 REMARK 620 5 ASP B 682 O 76.0 99.3 147.4 156.6 REMARK 620 6 ASP B 682 OD1 84.8 170.8 83.4 93.1 80.0 REMARK 620 7 GLU B 684 O 151.9 80.3 77.0 121.3 82.0 108.6 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 802 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 651 NE2 REMARK 620 2 ASP B 653 OD2 114.5 REMARK 620 3 HIS B 666 NE2 115.3 110.0 REMARK 620 4 HIS B 679 ND1 106.1 96.6 112.8 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 803 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 658 OD1 REMARK 620 2 GLY B 659 O 84.5 REMARK 620 3 GLY B 661 O 97.0 89.5 REMARK 620 4 VAL B 663 O 97.5 177.9 90.8 REMARK 620 5 ASP B 681 OD2 95.0 81.8 164.4 97.4 REMARK 620 6 GLU B 684 OE2 170.5 87.3 87.7 90.5 79.0 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 801 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 701 NE2 REMARK 620 2 HIS B 705 NE2 99.2 REMARK 620 3 HIS B 711 NE2 113.7 92.4 REMARK 620 4 111 B 901 OB 125.1 135.4 67.4 REMARK 620 5 111 B 901 OA 105.8 100.0 136.0 74.4 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 804 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 805 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 111 B 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CQR RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH A DIFFERENT INHIBITOR. REMARK 900 RELATED ID: 1D5J RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH A DIFFERENT INHIBITOR. REMARK 900 RELATED ID: 1D7X RELATED DB: PDB REMARK 900 1D7X CONTAINS THE SAME PROTEIN COMPLEXED WITH A DIFFERENT INHIBITOR. REMARK 900 RELATED ID: 1D8F RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH A DIFFERENT INHIBITOR. REMARK 900 RELATED ID: 1D8M RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH A DIFFERENT INHIBITOR. REMARK 900 RELATED ID: 1G05 RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH A DIFFERENT INHIBITOR. DBREF 1G49 A 83 255 UNP P08254 MMP3_HUMAN 100 272 DBREF 1G49 B 583 755 UNP P08254 MMP3_HUMAN 100 272 SEQRES 1 A 173 PHE ARG THR PHE PRO GLY ILE PRO LYS TRP ARG LYS THR SEQRES 2 A 173 HIS LEU THR TYR ARG ILE VAL ASN TYR THR PRO ASP LEU SEQRES 3 A 173 PRO LYS ASP ALA VAL ASP SER ALA VAL GLU LYS ALA LEU SEQRES 4 A 173 LYS VAL TRP GLU GLU VAL THR PRO LEU THR PHE SER ARG SEQRES 5 A 173 LEU TYR GLU GLY GLU ALA ASP ILE MET ILE SER PHE ALA SEQRES 6 A 173 VAL ARG GLU HIS GLY ASP PHE TYR PRO PHE ASP GLY PRO SEQRES 7 A 173 GLY ASN VAL LEU ALA HIS ALA TYR ALA PRO GLY PRO GLY SEQRES 8 A 173 ILE ASN GLY ASP ALA HIS PHE ASP ASP ASP GLU GLN TRP SEQRES 9 A 173 THR LYS ASP THR THR GLY THR ASN LEU PHE LEU VAL ALA SEQRES 10 A 173 ALA HIS GLU ILE GLY HIS SER LEU GLY LEU PHE HIS SER SEQRES 11 A 173 ALA ASN THR GLU ALA LEU MET TYR PRO LEU TYR HIS SER SEQRES 12 A 173 LEU THR ASP LEU THR ARG PHE ARG LEU SER GLN ASP ASP SEQRES 13 A 173 ILE ASN GLY ILE GLN SER LEU TYR GLY PRO PRO PRO ASP SEQRES 14 A 173 SER PRO GLU THR SEQRES 1 B 173 PHE ARG THR PHE PRO GLY ILE PRO LYS TRP ARG LYS THR SEQRES 2 B 173 HIS LEU THR TYR ARG ILE VAL ASN TYR THR PRO ASP LEU SEQRES 3 B 173 PRO LYS ASP ALA VAL ASP SER ALA VAL GLU LYS ALA LEU SEQRES 4 B 173 LYS VAL TRP GLU GLU VAL THR PRO LEU THR PHE SER ARG SEQRES 5 B 173 LEU TYR GLU GLY GLU ALA ASP ILE MET ILE SER PHE ALA SEQRES 6 B 173 VAL ARG GLU HIS GLY ASP PHE TYR PRO PHE ASP GLY PRO SEQRES 7 B 173 GLY ASN VAL LEU ALA HIS ALA TYR ALA PRO GLY PRO GLY SEQRES 8 B 173 ILE ASN GLY ASP ALA HIS PHE ASP ASP ASP GLU GLN TRP SEQRES 9 B 173 THR LYS ASP THR THR GLY THR ASN LEU PHE LEU VAL ALA SEQRES 10 B 173 ALA HIS GLU ILE GLY HIS SER LEU GLY LEU PHE HIS SER SEQRES 11 B 173 ALA ASN THR GLU ALA LEU MET TYR PRO LEU TYR HIS SER SEQRES 12 B 173 LEU THR ASP LEU THR ARG PHE ARG LEU SER GLN ASP ASP SEQRES 13 B 173 ILE ASN GLY ILE GLN SER LEU TYR GLY PRO PRO PRO ASP SEQRES 14 B 173 SER PRO GLU THR HET ZN A 301 1 HET ZN A 302 1 HET CA A 303 1 HET CA A 304 1 HET CA A 305 1 HET ZN B 801 1 HET ZN B 802 1 HET CA B 803 1 HET CA B 804 1 HET CA B 805 1 HET 111 B 901 28 HETNAM ZN ZINC ION HETNAM CA CALCIUM ION HETNAM 111 (1N)-4-N-BUTOXYPHENYLSULFONYL-(2R)-N- HETNAM 2 111 HYDROXYCARBOXAMIDO-(4S)-METHANESULFONYLAMINO- HETNAM 3 111 PYRROLIDINE FORMUL 3 ZN 4(ZN 2+) FORMUL 5 CA 6(CA 2+) FORMUL 13 111 C16 H25 N3 O7 S2 FORMUL 14 HOH *111(H2 O) HELIX 1 1 PRO A 109 GLU A 126 1 18 HELIX 2 2 LEU A 195 GLY A 208 1 14 HELIX 3 3 SER A 235 GLY A 247 1 13 HELIX 4 4 PRO B 609 GLU B 626 1 18 HELIX 5 5 LEU B 695 LEU B 707 1 13 HELIX 6 6 SER B 735 GLY B 747 1 13 SHEET 1 A 5 THR A 131 ARG A 134 0 SHEET 2 A 5 HIS A 96 ILE A 101 1 N LEU A 97 O THR A 131 SHEET 3 A 5 ILE A 142 ALA A 147 1 N ILE A 142 O THR A 98 SHEET 4 A 5 ALA A 178 ASP A 181 1 N ALA A 178 O MET A 143 SHEET 5 A 5 ALA A 165 ALA A 167 -1 O HIS A 166 N HIS A 179 SHEET 1 B 2 TRP A 186 THR A 187 0 SHEET 2 B 2 THR A 193 ASN A 194 1 O THR A 193 N THR A 187 SHEET 1 C 5 THR B 631 ARG B 634 0 SHEET 2 C 5 HIS B 596 ILE B 601 1 N LEU B 597 O THR B 631 SHEET 3 C 5 ILE B 642 ALA B 647 1 N ILE B 642 O THR B 598 SHEET 4 C 5 ALA B 678 ASP B 681 1 N ALA B 678 O MET B 643 SHEET 5 C 5 ALA B 665 ALA B 667 -1 O HIS B 666 N HIS B 679 SHEET 1 D 2 TRP B 686 THR B 687 0 SHEET 2 D 2 THR B 693 ASN B 694 1 O THR B 693 N THR B 687 LINK OD1 ASP A 107 CA CA A 304 1555 1555 2.61 LINK OD2 ASP A 107 CA CA A 304 1555 1555 2.39 LINK O ASP A 141 CA CA A 305 1555 1555 2.29 LINK NE2 HIS A 151 ZN ZN A 302 1555 1555 2.08 LINK OD2 ASP A 153 ZN ZN A 302 1555 1555 2.01 LINK OD1 ASP A 158 CA CA A 303 1555 1555 2.33 LINK O GLY A 159 CA CA A 303 1555 1555 2.33 LINK O GLY A 161 CA CA A 303 1555 1555 2.45 LINK O VAL A 163 CA CA A 303 1555 1555 2.29 LINK NE2 HIS A 166 ZN ZN A 302 1555 1555 2.03 LINK O GLY A 173 CA CA A 305 1555 1555 2.14 LINK O ASN A 175 CA CA A 305 1555 1555 2.30 LINK OD1 ASP A 177 CA CA A 305 1555 1555 2.41 LINK ND1 HIS A 179 ZN ZN A 302 1555 1555 1.97 LINK OD2 ASP A 181 CA CA A 303 1555 1555 2.45 LINK O ASP A 182 CA CA A 304 1555 1555 2.35 LINK OD1 ASP A 182 CA CA A 304 1555 1555 2.40 LINK OE2 GLU A 184 CA CA A 303 1555 1555 2.20 LINK O GLU A 184 CA CA A 304 1555 1555 2.48 LINK NE2 HIS A 201 ZN ZN A 301 1555 1555 2.14 LINK NE2 HIS A 205 ZN ZN A 301 1555 1555 2.11 LINK NE2 HIS A 211 ZN ZN A 301 1555 1555 2.36 LINK ZN ZN A 301 O THR B 755 1555 2464 2.72 LINK ZN ZN A 301 OXT THR B 755 1555 2464 1.88 LINK CA CA A 304 O HOH A 314 1555 1555 2.45 LINK CA CA A 304 O HOH A 316 1555 1555 2.41 LINK CA CA A 305 O HOH A 325 1555 1555 2.20 LINK CA CA A 305 O HOH A 326 1555 1555 2.32 LINK O HOH B 40 CA CA B 805 1555 1555 2.43 LINK O HOH B 44 CA CA B 805 1555 1555 2.35 LINK O HOH B 60 CA CA B 804 1555 1555 2.50 LINK O HOH B 86 CA CA B 804 1555 1555 2.52 LINK OD2 ASP B 607 CA CA B 804 1555 1555 2.40 LINK OD1 ASP B 607 CA CA B 804 1555 1555 2.54 LINK O ASP B 641 CA CA B 805 1555 1555 2.29 LINK NE2 HIS B 651 ZN ZN B 802 1555 1555 2.02 LINK OD2 ASP B 653 ZN ZN B 802 1555 1555 2.16 LINK OD1 ASP B 658 CA CA B 803 1555 1555 2.23 LINK O GLY B 659 CA CA B 803 1555 1555 2.30 LINK O GLY B 661 CA CA B 803 1555 1555 2.41 LINK O VAL B 663 CA CA B 803 1555 1555 2.34 LINK NE2 HIS B 666 ZN ZN B 802 1555 1555 2.04 LINK O GLY B 673 CA CA B 805 1555 1555 2.39 LINK O ASN B 675 CA CA B 805 1555 1555 2.31 LINK OD1 ASP B 677 CA CA B 805 1555 1555 2.42 LINK ND1 HIS B 679 ZN ZN B 802 1555 1555 2.11 LINK OD2 ASP B 681 CA CA B 803 1555 1555 2.42 LINK O ASP B 682 CA CA B 804 1555 1555 2.23 LINK OD1 ASP B 682 CA CA B 804 1555 1555 2.42 LINK OE2 GLU B 684 CA CA B 803 1555 1555 2.29 LINK O GLU B 684 CA CA B 804 1555 1555 2.40 LINK NE2 HIS B 701 ZN ZN B 801 1555 1555 2.25 LINK NE2 HIS B 705 ZN ZN B 801 1555 1555 2.28 LINK NE2 HIS B 711 ZN ZN B 801 1555 1555 2.14 LINK ZN ZN B 801 OB 111 B 901 1555 1555 2.25 LINK ZN ZN B 801 OA 111 B 901 1555 1555 1.94 SITE 1 AC1 4 HIS A 201 HIS A 205 HIS A 211 THR B 755 SITE 1 AC2 4 HIS A 151 ASP A 153 HIS A 166 HIS A 179 SITE 1 AC3 6 ASP A 158 GLY A 159 GLY A 161 VAL A 163 SITE 2 AC3 6 ASP A 181 GLU A 184 SITE 1 AC4 5 ASP A 107 ASP A 182 GLU A 184 HOH A 314 SITE 2 AC4 5 HOH A 316 SITE 1 AC5 6 ASP A 141 GLY A 173 ASN A 175 ASP A 177 SITE 2 AC5 6 HOH A 325 HOH A 326 SITE 1 AC6 4 HIS B 701 HIS B 705 HIS B 711 111 B 901 SITE 1 AC7 4 HIS B 651 ASP B 653 HIS B 666 HIS B 679 SITE 1 AC8 6 ASP B 658 GLY B 659 GLY B 661 VAL B 663 SITE 2 AC8 6 ASP B 681 GLU B 684 SITE 1 AC9 5 HOH B 60 HOH B 86 ASP B 607 ASP B 682 SITE 2 AC9 5 GLU B 684 SITE 1 BC1 6 HOH B 40 HOH B 44 ASP B 641 GLY B 673 SITE 2 BC1 6 ASN B 675 ASP B 677 SITE 1 BC2 18 PHE B 586 GLY B 588 ILE B 589 ARG B 593 SITE 2 BC2 18 ASN B 662 VAL B 663 LEU B 664 ALA B 665 SITE 3 BC2 18 LEU B 697 HIS B 701 GLU B 702 HIS B 705 SITE 4 BC2 18 HIS B 711 LEU B 718 TYR B 720 PRO B 721 SITE 5 BC2 18 LEU B 722 ZN B 801 CRYST1 37.668 77.112 106.145 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026548 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012968 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009421 0.00000